School of Medicine
Showing 1-50 of 92 Results
-
Uri Ladabaum
Professor of Medicine (Gastroenterology and Hepatology)
On Partial Leave from 2026-08-24 To 2027-01-29Current Research and Scholarly InterestsGastrointestinal cancer prevention and risk management. Risk stratification. Cost-effectiveness analysis. Health services research.
-
Richard Lafayette
Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsWe are continuing to grow a glomerulonephritis cohort study, including immunologic characterization. We have completed interventional studies of preeclampsia exploring the nitric oxide, endothelin system and effects on glomerular function and morphometry. We continue to recruit patients for treatment and observational studies of glomerular disease, including FSGS, membranous and particularly IgA nephropathy. We also are actively studying renal disease in systemic amyloidosis.
-
Sheila Lahijani, MD, FACLP
Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Professor (By courtesy), Medicine - OncologyBioDr. Lahijani is a Clinical Professor at Stanford University School of Medicine and a nationally recognized leader in psycho-oncology. With extensive training and expertise in internal medicine, psychiatry, and consultation-liaison psychiatry, she has made significant contributions to the integration of psychiatric care within oncological settings.
Since her appointment at Stanford in 2015, Dr. Lahijani has served as the lead psychiatric oncologist at the Stanford Cancer Center, where she provides medical psychiatric consultation services and collaborates with interdisciplinary teams to enhance patient outcomes. In her capacity as Medical Director of the Stanford Cancer Center Psychosocial Oncology Program, a position she has held since 2019, she is responsible for the strategic development and implementation of comprehensive psychiatric services tailored to the unique needs of patients with cancer.
Additionally, Dr. Lahijani serves as the Section Chief of Psycho-Oncology in the Division of Medical Psychiatry where she oversees psych-onc faculty development and leads the training of medical psychiatry fellows in psycho-oncology. She is the Faculty Director of the Psychosocial Oncology Clerkship for medical students. She serves as the Service Director for the Psycho-Oncology Track for the Consultation-Liaison Psychiatry Fellowship. Dr. Lahijani also supervises advanced practice providers and behavioral health clinicians while working as an attending psychiatric oncologist to provide care for patients with complex medical and psychiatric comorbidities across all hematology and oncology services.
Dr. Lahijani's academic credentials include her graduation from Brown Medical School, followed by the completion of a combined residency in Internal Medicine and Psychiatry at Rush University Medical Center. After completing residency, she practiced internal medicine and psychiatry with a focus on triple diagnosis (HIV, addiction medicine, mental health). She then further advanced through a Psychosomatic Medicine Fellowship at Northwestern University's Feinberg School of Medicine, during which time she received specialized training in psychiatric oncology at the Lurie Comprehensive Cancer Center and Memorial Sloan Kettering Cancer Center.
Her clinical expertise encompasses psychopharmacology and a range of treatment modalities, including Meaning Centered Psychotherapy and Dignity Therapy. Dr. Lahijani is committed to fostering relationship-centered skills and promoting provider wellness. As a faculty member of Advancing Communication Excellence at Stanford, she has led workshops designed to enhance communication competencies among faculty and staff.
Dr. Lahijani's scholarly pursuits are at the intersection of medicine and psychiatry, with a particular emphasis on the neuropsychiatric sequelae of cancer treatment, innovations in care, and medical education. She is dedicated to the education and mentorship of trainees in Psychiatry, Internal Medicine, Hematology/Oncology, Neurology, Geriatric Psychiatry, Palliative Medicine, and Breast Surgery. Through her commitment to academic excellence, Dr. Lahijani plays a pivotal role in preparing the next generation of clinicians, educators and scientists to understand and adeptly navigate the intricate and multifaceted needs of patients and their caregivers, thereby promoting a comprehensive approach to medicine. -
Fadi George Lakkis
Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsI study how the immune system rejects transplanted organs, with the goal of improving long-term transplant outcomes. A related area of research in my laboratory is the relationship between maternal-fetal immune interactions and reproductive success.
https://pubmed.ncbi.nlm.nih.gov/?term=Lakkis+FG%5BAuthor%5D&sort=date -
Rayhan A. Lal, MD
Assistant Professor of Medicine (Endocrinology) and of Pediatrics (Endocrinology)
BioI grew up in the east bay area and have had type 1 diabetes for 30+ years. I studied electrical engineering and computer science at U.C. Berkeley (Go Bears!) with the hope of applying my knowledge to diabetes technology. The significance of clinical practice became clear to me after my siblings also developed diabetes. I am devoting my life to advancing the care of diabetes in people of all ages.
-
Vinh Lam
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Vinh Lam is a Clinical Assistant Professor in the Department of Medicine, Division of Primary Care and Population health. He earned his MD from the David Geffen School of Medicine at UCLA and chose to stay in Los Angeles to complete his family medicine residency training at UCLA. During his training, Dr. Lam developed a strong interest in teaching and medical education through his involvement with resident education and the graduate medical education committee. He also spent 1 year as a resident informaticist where he also became very interested in informatics, medical technology, and innovative solutions to improving patient health outcomes and decreasing physician burnout. Dr. Lam enjoys caring for patients of all ages from pediatrics to geriatrics, performing office-based procedures, and prioritizing preventative care.
Outside of medicine, Dr. Lam loves to travel with his family, dabbles in photography and videography, and enjoys attempting to recreate meals he has had while traveling with his wife. -
Curtis Langlotz
Senior Associate Vice Provost for Research, Professor of Radiology (Integrative Biomedical Imaging Informatics), of Medicine, of Biomedical Data Science and Senior Fellow at the Stanford Institute for Human-Centered AI
Current Research and Scholarly InterestsMy laboratory develops machine learning methods to help physicians detect disease and eliminate diagnostic errors. My laboratory is developing neural network systems that detect and classify disease on medical images. We also develop natural language processing methods that use the narrative radiology report for contrastive learning and other multi-modal methods that improve the accuracy and capability of machine learning systems.
-
Benjamin Laniakea
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Benji Laniakea serves as the chief of the Stanford LGBTQ+ Adult Clinical Program, which offers comprehensive and tailored healthcare for the LGBTQ+ patient population for patients of all ages, sexualities, and gender identities. They also serve as the theme lead for the Sex, Gender, Sexuality, and Sexual Function curriculum at the Stanford School of Medicine for which they received the Arthur L. Bloomfield Award.
-
Tobias Lanz
Assistant Professor of Medicine (Immunology and Rheumatology)
BioTobias Lanz, MD is an Assistant Professor at the Institute for Immunity, Transplantation, and Infection and the Division of Immunology and Rheumatology at Stanford. His research focuses on B cell biology in neuroimmunological diseases and rheumatic diseases with neurological manifestations. He uses high-throughput screening technologies, and methods from structural and cell biology to identify new autoantigens and to understand how certain self-reactive B cells escape tolerance mechanisms. He is particularly interested in molecular mechanisms that explain the association between Epstein Barr Virus (EBV) and autoimmunity.
Tobias went to medical school at the Eberhard Karls University in Tübingen, Germany and at the University College of London. He wrote his MD thesis at Dr. Michael Platten's laboratory at the Hertie Institute for Clinical Brain Research in Tübingen, Germany before joining Dr. Lawrence Steinman’s neuroimmunological laboratory at Stanford as a research scholar. After medical school he pursued his scientific and clinical training at the German Cancer Research Center (DKFZ) and the Department of Neurology at the University Hospital in Heidelberg, Germany. In 2015 he joined Dr. William Robinson’s lab at Stanford, where he investigated environmental triggers of autoimmunity, including viruses and milk consumption. In his most recent work, he characterized the B cell repertoire in the spinal fluid of patients with multiple sclerosis (MS) and identified molecular mimicry between EBV EBNA1 and the glial cellular adhesion molecule GlialCAM as a driver of neuroinflammation (Lanz et al., Nature, 2022). His long term objective is to leverage these newly discovered mechanistic insights to develop next-generation biomarkers and therapeutics for autoimmune diseases. -
Megan Nicole Lau
Clinical Assistant Professor, Medicine
BioDr. Megan Lau is a Clinical Assistant Professor in the Division of Hospital Medicine at Stanford University School of Medicine. She earned her medical degree from UC San Diego, where she also completed her internal medicine residency as well as a hospice and palliative medicine fellowship. She practices as a hospitalist at Stanford Health Care and works with residents and students in clinical teaching. Her clinical interests include medical education, integrating primary palliative care within hospital medicine, and compassionate communication with both English and non-English speaking patients. Outside of medicine, she enjoys hiking, getting lost in a good book, and hosting lively dinner parties with friends.
-
Alice A. Lee
Instructor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsDr. Lee's research focuses on the early detection of pancreatic cancer, including the investigation of risk factors for pancreatic cancer and biomarkers to detect early cancer.
-
Byron Lee
Professor of Medicine (Cardiovascular)
BioDr. Byron Lee is Professor of Medicine in the Stanford Division of Cardiovascular Medicine and Cardiac Electrophysiology Section. He has published over 150 peer reviewed articles and 10 book chapters. He has written two books to help students navigate the medical school admission process: Insider's Premed Guidebook and Insider's High School Premed Guidebook. His research team studies treatments to prevent sudden cardiac death, atrial fibrillation, and complications of cardiac device lead extraction. He has won numerous teaching awards for his work with medical students, residents, and fellows. He currently teaches cardiovascular medicine and ECG reading at Stanford Medical School in the Practice of Medicine INDE 202, INDE 203, INDE 204 and INDE 205 courses. He also serves as Chief of Cardiac Electrophysiology at the Palo VA Medical Center and Head Cardiologist for University of California Athletics.
-
David Lee, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly Interests1. Novel treatments and devices for the treatment of valvular disease
2. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
3. Novel approaches to coronary revascularization
4. Closure devices for atrial septal defects and patent foramen ovale
5. Novel treatments for hypertension -
Jennifer Lee
Professor of Medicine (Endocrinology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsI am a healthcare lead and physician scientist for innovation, R&D, and advanced analytics, and oversee these aspects at VA Palo Alto/VHA, within Stanford-VA relationship. The VA has the US's largest health care system and longest running EHR. I prioritize enabling multiple partners (industry, government, academia, foundations), to innovate/R&D in the VA health care system. We prioritize mentoring students from various Schools to become future leaders in R&D, innovation, and healthcare.
-
Julie Jung Hyun Lee
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Julie J. Lee is a Clinical Assistant Professor of Medicine at Stanford University, board-certified in Internal Medicine, Obesity Medicine, and Clinical Informatics. She is the Health Equity Informaticist for Stanford’s Division of Primary Care and Population Health and Clinical Champion of the Stanford Metabolic Health Interventions and Lifestyle Empowerment Support (SMILES) Program. Her work advances two priorities: (1) augmenting the human practice of medicine through technology and (2) advancing precision health through innovation in obesity medicine.
With clinical experience in both hospital medicine and primary care, she leads human-centered innovation across inpatient and ambulatory settings at Stanford Health Care and Stanford Children’s Health. Her work includes award-winning prescription drug monitoring program (PDMP) EHR integration, recognized regionally and nationally, and an inpatient continuous glucose monitoring (CGM) policy at both hospitals. Her redesign of clinical decision support governance was adopted as standard practice by the Stanford Health Care Clinical Decision Support Committee and presented at Epic’s Expert Group Meeting. Building on this work, she is Principal Investigator of a emerging study examining how AI-enabled approaches to structuring patient histories may improve diagnostic reasoning, interprofessional team communication, and the usefulness of clinical notes.
In her obesity medicine practice, she is focused on advancing cardiovascular-kidney-metabolic (CKM) health. This builds on more than a decade of research in cardiovascular epidemiology and diabetes surveillance, including work with the Los Angeles County Department of Public Health and the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE). At Stanford, she collaborates with multidisciplinary teams to evaluate AI tools for diabetes and chronic disease management.
She has published in JAMA Network Open, the Journal of the American Heart Association, the Journal of General Internal Medicine, and the Annals of Family Medicine. She speaks at national and international conferences, academic grand rounds, and healthcare industry events on AI, health equity, and human-centered medicine.
Beyond her clinical and research work, Dr. Lee contributes to faculty and trainee development through mentorship, educational innovation, and institutional initiatives advancing professional growth, health equity, and a culture of human-centered medicine. Her experience includes curriculum development, interdisciplinary design thinking workshops, and leadership development through Stanford’s FACET and MODEL programs.
The medical humanities are foundational to her approach. An artist and musician first, she carries a humanistic perspective into her work, grounded in the belief that advances in science and technology should protect and preserve the essence of human creativity. -
Seolhyun Lee, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Lee is a nephrologist and Clinical Assistant Professor in the Nephrology Division of the Stanford Department of Medicine.
He delivers expert, compassionate kidney care personalized to each patient he serves. Dr. Lee is committed to improving both the health and quality of life of his patients.
His work scholarship has appeared in the Journal of the American Society of Nephrology, Kidney Week, and Blood Purification.
Dr. Lee has received honors and awards including the prestigious Ben J. Lipps Research Fellowship from the American Society of Nephrology. The program funds original research projects by nephrology fellows. -
Mary Leonard
Arline and Pete Harman Professor, Professor of Pediatrics (Nephrology), of Medicine (Nephrology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy multidisciplinary research program is focused on (1) the detrimental effects of glucocorticoids, sarcopenia and inflammation on bone development in pediatric diseases, (2) the long-term effects of childhood cancer on bone and muscle quality, (3) the assessment of renal osteodystrophy using novel micro-imaging techniques, (4) the effects of vitamin D deficiency on physical function and cardiovascular disease, and (5) the evaluation of biomechanical interventions as anabolic bone therapies.
-
John Leppert
Professor of Urology and, by courtesy, of Nephrology
Current Research and Scholarly InterestsOur research aims to improve the global quality of care for patients with Urologic Cancer with a particular focus on kidney cancer. We are investigating novel proteomic platforms and assays to diagnose kidney cancer and predict response to therapy. We are evaluating the comparative effectiveness of various kidney cancer surgeries and their impact on chronic kidney disease and its downstream effects. We are applying epidemiology, bioinformatics, and health services methods to urologic conditions.
-
Krystle Man-Chin Leung, MD
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Leung is a board-certified, fellowship-trained pulmonologist, intensivist, and sleep specialist with Stanford Health Care and a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine at Stanford University School of Medicine.
Dr. Leung specializes in pulmonology, critical care, and sleep medicine, focusing on sleep-disordered breathing, chronic lung disease, and ventilator management in the intensive care unit (ICU) and at home. Dr. Leung also focuses on patients with chronic obstructive pulmonary disease, chronic respiratory failure, neuromuscular respiratory weakness, obesity hypoventilation syndrome, restrictive lung disease, and sleep apnea. She provides compassionate, patient-centered care, emphasizing shared decision-making and aligning medical treatments with patients’ values and preferences.
Dr. Leung’s research interests include optimizing care for patients who require home ventilation and those who have or have survived critical illnesses. She has prior research experience in prolonged mechanical ventilation, thoracic imaging, and asthma.
Dr. Leung has published her work in numerous peer-reviewed journals and presented at national conferences.
Dr. Leung is a member of the American Academy of Sleep Medicine, the American College of Chest Physicians, and the American Thoracic Society. -
Lawrence Leung
Maureen Lyles D'Ambrogio Professor in the School of Medicine
On Partial Leave from 2026-09-01 To 2027-08-31Current Research and Scholarly InterestsOur long term interest is to have a better understanding of the natural antithrombotic pathways and the pathophysiology of vascular thrombosis. We have focused on thrombin, the key enzyme in the blood clotting cascade.Our goal is to develop new antithrombotic agents and devise new diagnostic tests for vascular thrombotic disorders.
-
Eleanor Levin
Clinical Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsCardiovascular Value Based Care, Cardio-Obstetrics, Dyslipidemia Treatment
-
Deborah J Levine, MD, FCCP, FAST
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Deborah Jo Levine is a board-certified pulmonologist and lung transplantation and pulmonary hypertension specialist. She is a clinical professor of medicine in the Department of Pulmonary, Allergy, and Critical Care Medicine. Dr. Levine also serves as director of lung transplant outreach for Stanford Health Care.
Dr. Levine is internationally recognized for her work in lung transplantation and pulmonary hypertension (PH). She has been instrumental in developing international guidelines for defining, diagnosing, and managing antibody-mediated rejection (AMR) after lung transplantation. She has served as chair of pulmonary AMR guidelines for the International Society of Heart and Lung Transplantation.
Dr. Levine’s research interests include lung allograft monitoring and risk assessment. Her research has also included monitoring lung allograft health using donor-derived cell-free DNA (dd-cfDNA)—a technique pioneered at Stanford Medicine. She has received National Institutes of Health (NIH) funding as a clinical investigator. Dr. Levine is a co-chair of the ALAMO (AlloSure Lung Assessment and Metagenomics Outcomes) Study national registry. She has been involved in many clinical trials in lung transplantation and pulmonary hypertension.
As a respected educator and researcher, Dr. Levine has led and contributed to dozens of abstracts, presentations, and peer-reviewed articles. She has also written several books and book chapters on pulmonary hypertension, interstitial lung disease, pulmonary vascular disorders, and lung transplantation.
Dr. Levine is editor-in-chief for Advances in Pulmonary Hypertension, the quarterly journal of the Pulmonary Hypertension Association. She is an editorial board member of The Journal of Heart and Lung Transplantation and an ad hoc reviewer for several other industry journals. Dr. Levine also serves as a grant reviewer and section study reviewer for the American College of Chest Physicians and the American Society of Transplantation.
Dr . Levine is a fellow of the American College of Chest Physicians and the American Society of Transplantation. She is also the chair of the Diffuse Lung Disease and Lung Transplant Network and the incoming vice chair of the Council of Networks for the American College of Chest Physicians (CHEST). -
Joseph Levitt, MD, MS
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsMy research focuses on the physiolgogic and biomarker characteristics of early acute lung injury (ALI) prior to need for mechanical ventilation. While, to date no pharmacologic treatment has improved survival in ALI, following the paradigm of early goal directed therapy for severe sepsis, clinical benefit may derive from identifying patients and initiating treatment prior to the need for positive pressure ventilation (and therefore prior to meeting current study entry criteria).
-
Lee Levitt
Professor of Medicine (Hematology) at the Santa Clara Valley Medical Center, Emeritus
Current Research and Scholarly InterestsLow molecular-weight heparins Clinical trials with anti-thrombotics Clinical trials in patients with leukemia, breast cancer and myeloma Medical education.
-
Ronald Levy, MD
Robert K. and Helen K. Summy Professor in the School of Medicine
Current Research and Scholarly InterestsClinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer.
-
Eldrin F. Lewis, MD, MPH
Simon H. Stertzer, MD, Professor
BioDr. Lewis is a board-certified, fellowship-trained specialist in cardiovascular medicine. He is the chief of the Division of Cardiovascular Medicine and a professor of cardiovascular medicine.
Dr. Lewis is an esteemed clinician-scientist who specializes in the care of patients with advanced heart failure. He is an internationally recognized expert on heart failure, heart transplant, and quality of life for heart failure patients. He cares deeply about his patients as well as his colleagues, the hospital, and the School of Medicine. Dr. Lewis is committed to diversity and inclusion, as well as expanding Stanford clinical research initiatives.
A fundamental principle of Dr. Lewis’ practice is his belief that “there is more to life than death,” that cardiovascular care should go beyond helping patients survive to also helping them enjoy the best possible quality of life.
Dr. Lewis has deep expertise in conducting clinical trials examining diagnostic and therapeutic approaches to heart failure. He has done innovative work to create systems for incorporating quality of life measures for cardiovascular patients into electronic health records. This research has received support from the National Heart, Lung and Blood Institute and the National Institutes of Health.
Much of his quality of life research has focused on patient-reported outcomes. Dr. Lewis emphasizes the importance of looking at how a disease, whether chronic or acute, impacts people’s ability to function and perform their activities of daily living. Strategies to improve patients’ well-being focus not only on their physical symptoms but also on depression, anxiety, exercise capacity, and ability to function in daily living.
Dr. Lewis’ commitment to expanding clinical research initiatives will give patients more opportunities to participate in the clinical trials and access the latest care strategies that can translate into better outcomes. The goal is early access to the most advanced technology, pharmacology, and device therapy that can change outcomes for the better. He also envisions forming closer partnerships with community cardiologists and capitalizing further on Stanford’s proximity to and unique relationships with the digital technology leaders of Silicon Valley to enhance the use of digital technology for monitoring patients, optimizing treatment, and tracking outcomes.
He has authored nearly 200 articles published in peer-reviewed journals including the New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, JAMA Cardiology, JAMA Internal Medicine, and many more. He is also on multiple editorial boards for cardiovascular journals and was an associate editor for Circulation–Heart Failure. In addition, he is an author of professional society clinical practice guidelines and scientific statements from both the American Heart Association (AHA) and the Food and Drug Administration.
Dr. Lewis’ honors for clinical care, scholarship, and research include the Joel Gordon Miller Award for community service and leadership from the University of Pennsylvania School of Medicine. He also was one of the first recipients of the Minority Faculty Development Award, which recognizes the research potential of young physicians. Dr. Lewis has received a grant from the Robert Wood Johnson Foundation to study the role of quality of life assessment in clinical decision making in patients with heart failure.
He is a fellow of the American College of Cardiology and the National American Heart Association (AHA) Research Committee. In addition, Dr. Lewis was as a member of the AHA Founders Affiliate Board of Directors, chair of the Council on Clinical Cardiology, and research chair of the Association of Black Cardiologists. He also serves on scientific committees to review grants for the AHA and on the FDA Task Force for the Standardization of Definitions for Endpoint Events in Cardiovascular Trials. -
Andrew A. Li, MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Li is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care. He is a clinical assistant professor in the Department of Medicine, Division of Gastroenterology and Hepatology at Stanford University School of Medicine.
A therapeutic endoscopy specialist, Dr. Li received fellowship training in gastroenterology, advanced endoscopy, and endoscopic surgery at Stanford University School of Medicine. He is board certified in internal medicine and gastroenterology.
Dr. Li specializes in advanced endoscopic procedures. His areas of expertise include endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), enteroscopy, endoscopic mucosal resection (EMR), and endoscopic submucosal dissection (ESD). He also specializes in esophageal peroral endoscopic myotomy (POEM), gastric peroral endoscopic myotomy (GPOEM), and Zenker’s diverticulum peroral endoscopic myotomy (ZPOEM).
In addition, he treats gastrointestinal cancers, including gastric (stomach) cancer and colon cancer. He is dedicated to helping patients by integrating leading-edge research and innovations with compassionate, patient-centered clinical care.
Dr. Li’s research interests include gastric cancer, innovations in advanced endoscopy and endoscopic surgery, and the application of artificial intelligence (AI) and other computational techniques for prevention, diagnoses, and treatments.
Dr. Li has published articles in the World Journal of Gastrointestinal Endoscopy, Gastrointestinal Endoscopy, and Endoscopy International Open. He has presented at national and international conferences held in Las Vegas; Washington, D.C.; and Seoul, Korea. In his many presentations, he has covered topics such as the prevention of gastric cancer and prevention of post-ERCP pancreatitis.
Dr. Li is a member of the American Society for Gastrointestinal Endoscopy, American College of Gastroenterology, American Gastroenterological Association, and American College of Physicians. -
Daniel Yuhang Li
Instructor, Medicine - Cardiovascular Medicine
BioI am a physician scientist in the Division of Cardiology at Stanford. My clinical interest is at the intersection of inflammation, autoimmunity and cardiovascular disease in a field called 'Cardio-Rheumatology'. Patients with rheumatologic diseases typically have an elevated cardiovascular disease risk profile along with an insidious onset. Moreover, with the ever-expanding biologic drug formulary for patients, it is important for us to characterize the cardiovascular effects of these medications. In my research, I believe that understanding how inflammatory and autoimmune mechanisms modify coronary artery disease can help us develop a novel perspective towards treating atherosclerosis beyond lipid lowering. My research goal is to advance novel therapeutics for atherosclerosis by leveraging my expertise in genetics, computational biology, and experience with diverse model organism perturbation models. My strategy employs a ‘systems’ approach, starting with human population variations at the genetic level and integrating findings across RNA, protein, and model organism studies. This comprehensive synthesis aims to grasp the overarching biological narrative, thereby facilitating the development of translational therapies that transform concepts from bench to bedside.
-
Ron Li
Clinical Associate Professor, Medicine
BioRon Li is a Clinical Associate Professor of Medicine in the Division of Hospital Medicine and Center for Biomedical Informatics Research at Stanford University School of Medicine. As the Medical Informatics Director for Digital Health at Stanford Health Care, he provides medical and informatics direction for the health system's enterprise digital health portfolio, including expanding digital referral networks and virtual care modalities. He is also the founding Medical Director for Stanford Health Care at Home and the co-founder and Director for the Stanford Emerging Applications Lab (SEAL), which helps clinicians and staff build ideas into novel digital products that are prototyped and tested for care delivery at Stanford Health Care.
Ron's academic interests focus on the "delivery science" of new technological capabilities such as digital and artificial intelligence in healthcare and how to design, implement, and evaluate new tech enabled models of care delivery. Ron's work spans across multiple disciplines, including clinical medicine, data science, digital health, information technology, design thinking, process improvement, and implementation science. He has consulted for various companies in the digital health and artificial intelligence space. He is an attending physician on the inpatient medicine teaching service at Stanford Hospital and is the Associate Program Director for the Stanford Clinical Informatics Fellowship. -
Serena Lian
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioSerena Lian, MD, CAQSM, is a double board-certified family medicine and sports medicine physician in the Division of Primary Care and Population Health (PCPH) and a clinical assistant professor at Stanford University School of Medicine. Her clinical interests include complex acute and chronic care, sports medicine, dermatology, women's health, ultrasound, and medical education.
Dr. Lian grew up in Louisville, KY and attended college at Yale, followed by medical school at the University of North Carolina. She completed family medicine residency at Inova Fairfax Hospital and sports medicine fellowship at the University of Colorado, where she served as a team physician for the NCAA D1 volleyball and football teams. Additionally, she has provided medical coverage for the Denver Nuggets (NBA) and Colorado Avalanche (NHL) and volunteered with several U.S. Olympic and Paralympic national teams.
Dr. Lian is passionate about helping patients of all ages optimize their baseline health and comfortably manage their medical conditions. Her sports medicine training also allows her to provide non-surgical treatment options for patients suffering from acute or overuse injuries as well as degenerative conditions including arthritis and chronic tendinopathy. She is also passionate about mentorship, particularly for students and trainees from backgrounds that are traditionally underrepresented in medicine. -
Emily C. Liang, MD
Assistant Professor of Medicine (Blood and Marrow Transplantation & Cellular Therapy)
BioDr. Liang is an Assistant Professor in the Division of Blood and Marrow Transplantation & Cellular Therapy. She cares for patients with multiple myeloma and other plasma cell disorders receiving cellular therapies. She graduated from Stanford University with a BA in Human Biology and earned her MD from the David Geffen School of Medicine at UCLA. She completed internal medicine residency at Stanford University and hematology/oncology fellowship at the University of Washington and Fred Hutchinson Cancer Center.
Dr. Liang's research integrates clinical investigation, statistical modeling, and translational science to characterize, predict, and mitigate CAR T-cell therapy-associated toxicities and advance cellular therapies for multiple myeloma. Her work has been published in Blood, Blood Advances, Transplantation and Cellular Therapy, and Bone Marrow Transplantation and has been funded by the National Institutes of Health, Conquer Cancer, and Swim Across America. -
April Shichu Liang
Clinical Assistant Professor, Medicine
BioApril S. Liang, M.D., is a Board-Certified internist and Clinical Informaticist. She serves as Clinical Assistant Professor in the Stanford Division of Hospital Medicine as well as Medical Informatics Director. Dr. Liang holds a B.S.E. in Computer Science from Princeton University and an M.D. from UCSF School of Medicine. She completed Internal Medicine residency at UCSF and Clinical Informatics fellowship at Stanford. Dr. Liang’s informatics interests include the implementation of AI tools in healthcare and data-driven quality improvement. Her past work includes the integrating a machine learning-driven clinical decision support tool in the EHR targeting lab overutilization and measuring the impact of ambient AI scribes on clinician documentation time.
-
Charles Liao
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsEducational Curriculum: Working with Professional Interpreters
-
Ronglih Liao
Douglass M. and Nola Leishman Professor of Cardiovascular Disease
BioDr. Liao is a Professor of Medicine and co-Director of Stanford Cardiac Amyloid Center. The major goal of her research program focuses on understanding the mechanisms that underlie the pathophysiology of heart failure and developing novel treatments to combat this process. Her laboratory has played an international leading role in the study of amyloid light chain (AL) cardiomyopathy, a rare and fatal form of cardiovascular disease. We have described the underlying pathophysiologic basis for amyloid cardiomyopathy and found that the circulating amyloidogenic light chain proteins that characterize this disease directly result in a specific cardiotoxic response. Consequently, our research work has redefined AL cardiomyopathy and has raised new treatment approaches. More recently, her research efforts have expanded to include transthyretin (ATTR) cardiac amyloidosis.
In line with her goal of revealing novel therapeutic strategies for patients with cardiovascular disease, our efforts have also focused on characterizing and harnessing endogenous cardiac regenerative mechanisms. Her laboratory initially demonstrated the therapeutic potential of exogenous primitive muscle cells delivered to the injured heart. This work was among the earliest milestones in the field and served as the basis for an international trial of cell-based therapy. Subsequently, Liao lab identified and characterized a population of cardiac progenitor cells and its relationship and dynamic activity following cardiac injury in the adult heart. Her laboratory aims to reveal the molecular mechanisms regulating the endogenous regenerative capacity of the heart and to harness such repair mechanisms for the treatment of cardiovascular disease. Dr. Liao has lectured extensively on both amyloid cardiomyopathy and stem cell biology, and have maintained a history of independent NIH funding in these areas for more than two decades.
Over the course of her academic career, she has taken the greatest pride in mentoring the next generation of scientists. Dr. Liao has had the privilege to supervise several dozen students, postdoctoral fellows, and junior faculty, many of whom have gone on to independent academic careers at the highest institutions. Her contribution to the advancement of scientific knowledge also includes lecturing at various university and academic institutions as well as at scores of conferences and symposia locally, nationally, and internationally.